EDITIONEN·FR·ქართ

Accréditation Sans Frontières

International Accreditation of Healthcare Facilities

Standards › Standard 2A › Policies

Policy · GOV-POL-005 · Version 1.1 · Approved by the ASF Expert Committee

Supports: 2A.10

At a glance

  • At least one patient or family representative has a written role in quality review or governance discussion.
  • The representative is invited to quality meetings and receives the papers in advance.
  • The representative can raise items and their input is recorded in the minutes.
  • The facility reports back to the representative on what changed as a result.
  • Stop and get help straight away if: a representative raises a concern that is not recorded or answered in writing.

1. Purpose

To make sure patients and families have a structured role in improving governance and quality, not only indirect input through complaints and surveys [E-006, EC].

2. Scope

Applies to The governing body, quality committee, and the representative(s) appointed
Locations Governing body and quality committee meetings
When At each scheduled meeting where quality and safety are discussed
Does not apply to Individual patient complaints, which are handled under INC-POL-002

3. Definitions

Term Meaning
Representative A patient, former patient or family member who has agreed to a structured role, with a written role description
Written role A document setting out the representative’s duties, term, expenses and support

4. Background

Patients and families see things staff may not see. Criterion 2A.10 asks for a structured role, which means a named person, a written role and a record of what they contributed.

5. Responsibilities

Role Responsibility Competence
Governing body Agrees the written role and appoints the representative Governance training
Quality lead Invites the representative; sends papers; records input Quality governance
Representative Attends, prepares, raises patient and family views Training and support (EC)
Chief executive Responds in writing to the representative’s input Executive leadership

6. Materials and equipment

Item Requirement Condition
Written role description Current; signed by the representative and the chair Dated and signed
Attendance register (GOV-REG-004) Current Completed each meeting

7. Safety

8. Before you start

9. Procedure

Step 1. Agree the written role.

  • Write the role description: purpose, duties, term (for example two years), expenses, support, and confidentiality.
  • The representative and the chair sign it.

Key point: A written role gives the representative standing and tells everyone what to expect.

Step 2. Invite and prepare the representative.

  • Invite the representative to each quality and governance meeting where safety or quality is discussed.
  • Send papers in plain language, with an explanation of technical terms.
  • Offer a briefing before the first meeting.

Key point: A representative who cannot follow the papers cannot contribute.

Step 3. Record their input.

  • Record each contribution in the minutes (GOV-FRM-003), with the response.
  • Make sure the representative is asked for input on each agenda item where patients are affected.

Key point: If input is not in the minutes, it did not happen for the governing body.

Step 4. Respond in writing.

  • The chief executive responds in writing to each concern or suggestion within 30 days.
  • Explain what will change and what will not, with reasons.

Key point: A response is what makes the representative’s role matter.

Step 5. Report back to patients.

  • Share the outcomes of the representative’s input with patients through the patient council and the notice board every six months.

Key point: Patients should see that their voice changed something.

Step 6. Review the role each year.

  • Review the role description, the term and the support yearly with the representative.
  • Record the review.

Key point: Roles that are not reviewed become decoration.

10. Decision points

11. Special situations

Situation Action
No representative available The governing body records the vacancy and the steps taken to recruit; the role is not filled by a staff member.

12. Escalation

13. Monitoring

Measure Target Frequency Owner If not met
Representative appointed with written role Yes Yearly Governance lead Escalate to governing body
Meetings attended by the representative 80% (EC) Quarterly Governance lead Review invitations and support
Input recorded with a response 100% Each meeting Governance lead Chair reviews minutes

14. Records

Record Kept in Retention
Written role description Governance file Duration of role plus the period set by the facility’s records policy years
Attendance register (GOV-REG-004) Governance file the period set by the facility’s records policy years
Minutes with the representative’s input Governance file the period set by the facility’s records policy years

15. Training

16. Related documents

ID Title Use
CON-POL-003 Patient Council Terms of Reference Patient council works alongside the representative
GOV-REG-004 Attendance Register Attendance record
INC-POL-002 Complaints and Feedback Individual complaints route
GOV-POL-001 Governing Body Terms of Reference Authority

17. Evidence

Reference Note
E-006 ASF Policy Framework v1.2. Adapted.
E-009 ASF Expert Committee consensus. Term, expenses and number of representatives are EC decisions.

18. Change history

Version Date What changed Approval
1.0 the date of approval First version Approved by the ASF Expert Committee
1.1 the date of approval Internal quality review: corrected cross-references, status wording and document control Approved by the ASF Expert Committee

E-learning for this document

References

Download this document as PDF
© 2026 Accréditation Sans Frontières · PHIG · Sheni Network